Evaluating the efficacy of local corticosteroid injection, platelet-rich plasma, and Extracorporeal shockwave therapy in patients with Pes Anserine bursitis

Not Applicable

• Conditions: Musculoskeletal Diseases; Orthopaedics

• Registration Number: PACTR202302648824229
• Lead Sponsor: Al Azhar University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-10-19
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Patients are clinically diagnosed with chronic pes anserine bursitis by a rheumatologist based on Larson and Baum's criteria:
- Pain in the anteromedial area of the knee, especially when moving uphill or downstairs
- Morning discomfort and stiffness lasting more than an hour
- Nocturnal pain; and difficulty rising from a chair or getting out of a car.
- Resistant to traditional treatments such as NSAIDs and Physiotherapy.

Exclusion Criteria

- blood disorders
- pacemakers
- paresis of lower limbs
- active malignancy or infection
- pregnancy
- fractures
- having undergone knee surgery
- Patients who declined to participate in the trial
- those allergic to corticosteroid injections,
- those suffering from fibromyalgia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Western Ontario and McMaster Universities (WOMAC) pain score;WOMAC physical function score

Secondary Outcome Measures

Name	Time	Method
Ritchie score for tenderness